Drug recall · September 30, 2026
Olanzapine Tablets recall
Why: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.
- Lots / codes
Lot: BOB22321A, Exp 07-31-2027.
- Quantity
- 22,032 30-count bottles
- Company
- Macleods Pharmaceuticals Limited, Tehsil Baddi, District Solan
- Distribution
- Nationwide in the USA
- Initiated
- August 27, 2026 · Voluntary: Firm initiated
- Classified
- September 22, 2026
- Reported
- September 30, 2026
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olanzapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.